Journal
JOURNAL OF THE INTENSIVE CARE SOCIETY
Volume 21, Issue 3, Pages 241-246Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1751143719896554
Keywords
Sepsis; nanotechnology; diagnosis; infection; biomarkers
Categories
Funding
- NIHR Academic Clinical Fellowship (AC) at the University of Manchester
Ask authors/readers for more resources
The urgent need to start anti-infective therapeutic interventions in suspected sepsis, and the lack of specific time-critical diagnostic information often lead to the widespread administration of broad-spectrum antimicrobial therapies, increasing the risk of unwanted patient harms and contributing to rising pathogen antimicrobial resistance. Nanotechnology, which involves engineering at the nanoscale, allows for the bespoke development of diagnostic solutions with multi-functionality and high sensitivity that has the potential to help provide time-critical information to make more accurate diagnoses and treatment decisions for sepsis. Nanotechnologies also have the potential to improve upon the current strategies used for novel biomarker discovery. Here we describe some of the current limitations to identifying sepsis and explore the potential role for nanotechnology solutions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available